title: Comparative activities of the enantiomeric GABA(B) receptor agonists CGP 44532 and 44533 in central and peripheral tissues.
abstract: In neocortical slices maintained in Mg(2+)-free Krebs medium, the gamma-aminobutyric acid (GABA(B)) receptor agonists baclofen, (3-amino-2(S)-hydroxypropyl)methylphosphinic acid (CGP 44532), and its (R)-enantiomer CGP 44533 depressed the frequency of spontaneous discharges in a concentration-dependent manner (EC(50)=10, 6.5, and 50 microM, respectively). These effects were reversibly antagonised by the GABA(B) receptor antagonist (+)-(S)-5,5 dimethylmorpholinyl-2-acetic acid (Sch 50911) (3, 10, and 30 microM) (average pA(2) value=6.0+/-0.2). In neocortical wedges, baclofen, CGP 44532 and CGP 44533 elicited concentration-dependent hyperpolarisations (the EC(50)s were 14, 7.5 and 16 microM, respectively) sensitive to Sch 50911 (1, 5, 10 microM) (average pA(2) value=6.0+/-0.1), whilst they also depressed ileal electrically elicited cholinergic twitch contractions (EC(50)=11, 7, and 50 microM) that were antagonised by Sch 50911 (average pA(2) value=6.0+/-0.1). In electrically stimulated brain slices preloaded with [3H]GABA, baclofen, CGP 44532 and CGP 44533 decreased [3H]GABA release (IC(50)=5, 0.45, and 10 microM); this effect was reversed by Sch 50911 (50 microM). It is concluded that CGP 44532 is a far more potent agonist at GABA(B) autoreceptors than at central or peripheral heteroreceptors.
authors.affiliation: Department of Anaesthesia and Intensive Care, The University of Adelaide, South Australia 5005, Australia. jennifer.ong@adelaide.edu.au
authors.forename: J
authors.initials: J
authors.lastname: Ong
authors.forename: S
authors.initials: S
authors.lastname: Bexis
authors.forename: V
authors.initials: V
authors.lastname: Marino
authors.forename: D A
authors.initials: DA
authors.lastname: Parker
authors.forename: D I
authors.initials: DI
authors.lastname: Kerr
authors.forename: W
authors.initials: W
authors.lastname: Froestl
mesh_terms: D000818:Animals; D001418:Baclofen / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D058786:GABA-B Receptor Agonists; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects* / Q000502:physiology; D008297:Male; D019579:Neocortex / Q000187:drug effects* / Q000502:physiology; D063065:Organophosphonates / Q000494:pharmacology*; D010721:Phosphinic Acids; D051381:Rats; D017207:Rats, Sprague-Dawley; D018080:Receptors, GABA-B / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*
chemical_list: C112036:3-amino-2-(S)-hydroxypropyl-methyl-phosphinic acid; D058786:GABA-B Receptor Agonists; D063065:Organophosphonates; D010721:Phosphinic Acids; D018080:Receptors, GABA-B; D005680:gamma-Aminobutyric Acid; D001418:Baclofen